{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T19:32:57Z","timestamp":1768591977662,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.anl.2018.05.007","type":"journal-article","created":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T19:22:18Z","timestamp":1528917738000},"page":"141-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab"],"prefix":"10.1016","volume":"46","author":[{"given":"Isao","family":"Suzaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurika","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3771-486X","authenticated-orcid":false,"given":"Akihiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Mizuyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Kitajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6567-1054","authenticated-orcid":false,"given":"So","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Hinohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitome","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2018.05.007_bib0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/MAO.0b013e3181bc3781","article-title":"Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media","volume":"31","author":"Iino","year":"2010","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2018.05.007_bib0010","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/MAO.0b013e318263d5b8","article-title":"Clinical efficacy of anti-IgE therapy for eosinophilic otitis media","volume":"33","author":"Iino","year":"2012","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2018.05.007_bib0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4168\/aair.2013.5.3.175","article-title":"Improvement of eosinophilic otitis media by optimized asthma treatment","volume":"5","author":"Tanaka","year":"2013","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.anl.2018.05.007_bib0020","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1182\/blood.V79.11.2952.bloodjournal79112952","article-title":"Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects","volume":"79","author":"Sehmi","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.anl.2018.05.007_bib0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1084\/jem.167.1.43","article-title":"Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors","volume":"167","author":"Yamaguchi","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.anl.2018.05.007_bib0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1183\/09059180.00004013","article-title":"Anti-interleukin-5 therapy in severe asthma","volume":"22","author":"Garcia","year":"2013","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.anl.2018.05.007_bib0035","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2018.05.007_bib0040","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2018.05.007_bib0045","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jaip.2017.04.024","article-title":"Biotherapeutics in chronic rhinosinusitis with and without nasal polyps","volume":"5","author":"Bachert","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anl.2018.05.007_bib0050","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.anl.2010.11.016","article-title":"Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease","volume":"38","author":"Iino","year":"2011","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2018.05.007_bib0055","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3109\/00016489.2013.868601","article-title":"Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media","volume":"134","author":"Iino","year":"2014","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.anl.2018.05.007_bib0060","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.anl.2014.08.003","article-title":"Risk factors associated with severity of eosinophilic otitis media","volume":"41","author":"Kanazawa","year":"2014","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2018.05.007_bib0065","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","article-title":"Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study","volume":"187","author":"Hanania","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anl.2018.05.007_bib0070","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/j.1365-2222.2005.02330.x","article-title":"Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media","volume":"35","author":"Iino","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anl.2018.05.007_bib0075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.anai.2014.04.021","article-title":"Antigen-specific IgE in middle ear effusion of patients with eosinophilic otitis media","volume":"113","author":"Kanazawa","year":"2014","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814617307848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814617307848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:34:31Z","timestamp":1759952071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814617307848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0385814617307848"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2018.05.007","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2018.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}